A9Add image
AOD-9604 + CJC-1295 + Ipamorelin Blend
Weight LossBlendComponents: AOD-9604, CJC-1295 (No DAC), Ipamorelin
A three-peptide fat-loss focused blend combining AOD-9604's lipolytic action with a GHRH/GHRP duo to elevate GH.
Half-life
1 h
Common dose
250 – 500 mcg
Dosing frequency
Daily
Administration
Subcutaneous
How it works
AOD-9604 directly stimulates lipolysis; CJC-1295 + Ipamorelin pulse GH (which itself enhances lipolysis and lean tissue preservation). Net effect is multi-pathway support for body recomposition.
Protocol notes
Typical dosing splits the blend into 1–3 daily injections totaling ~250 mcg AOD + ~100 mcg each of CJC-1295 and Ipamorelin. 8–12 week cycles.
Reported side effects
Combined profile of all three; injection-site reactions most common.